Top

Global Hepatitis B and C Diagnostics Market 2016-2020

Category : Diagnostic and Biotech  | Published Date : Aug-2016 | Pages : 110
enquire GET DISCOUNT
About Hepatitis B and Hepatitis C

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

Technavio’s analysts forecast the global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global hepatitis B and C diagnostics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of immunodiagnostics and nucleic acid test (NAT) instruments and consumables to hospitals, diagnostic centers, and research institutes.

The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA

Technavio's report, Global Hepatitis B and C Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
• Abbott Diagnostics
• Roche Diagnostics
• Siemens Healthcare
• QIAGEN

Other prominent vendors 
• Affymetrix
• Allele Biotechnology
• Axis-Shield
• Becton Dickinson
• bioMérieux
• Cepheid
• Chembio Diagnostics
• DiaMetra
• DiaSorin
• Enzo Life Sciences
• Hologic
• ImmunoDX
• MedMira
• OraSure Technologies
• Quest Diagnostics
• Quidel
• Randox Laboratories
• Vela Diagnostics
• Vital Diagnostics
• ZEUS Scientific

Market driver 
• Strategies of healthcare organizations toward simplifying the diagnostic process
• For a full, detailed list, view our report 

Market challenge 
• Regulatory and reimbursement hurdles limit the adoption rate
• For a full, detailed list, view our report 

Market trend 
• Advent of immunosensors in the HBV and HCV diagnostic tests
• For a full, detailed list, view our report 

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors? 

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.







PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Hepatitis B and C diagnostics: An overview
• Hepatitis B disease overview
• Hepatitis C disease overview
PART 05: Reimbursement scenario: An overview
PART 06: Market landscape
• Market overview
• Global hepatitis B and C diagnostics market overview
• Five forces analysis
PART 07: Market segmentation by procedure
• Immunodiagnostics
• Immunofluorescence
• Instruments
• Reagents
• Global hepatitis B and C immunodiagnostics market overview
• NAT
• Global hepatitis B and C NAT market overview
PART 08: Market segmentation by disease
• Hepatitis B
• Global hepatitis B diagnostics market overview
• Hepatitis C
• Global hepatitis C diagnostics market overview
PART 09: Geographical segmentation
• Hepatitis B and C diagnostics market in Americas
• Hepatitis B and C diagnostics market in EMEA
• Hepatitis B and C diagnostics market in APAC
PART 10: Market drivers
• Growing demand for molecular diagnostics in the diagnosis of HBV and HCV
• Strategies of healthcare organizations toward simplifying the diagnostic process
• Rising demand for POC diagnostics
• Increase in demand for automation and system integration
PART 11: Impact of drivers
PART 12: Market challenges
• Presence of high undiagnosed individuals
• Limited detection capability and complexity of assays
• Regulatory and reimbursement hurdles limit the adoption rate
• Limitations of closed systems
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Advent of immunosensors in the HBV and HCV diagnostic tests
• Paradigm shift toward the use of hepatitis C core antigen test
• High demand for biomarker-based tests
PART 15: Vendor landscape
• Competitive scenario
• Key news
PART 16: Key vendor analysis
• Abbott Diagnostics
• Roche Diagnostics
• Siemens Healthcare
• QIAGEN
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Possible outcomes of HBV infection
Exhibit 03: Concentration of HBV in several body fluids
Exhibit 04: Pathway of hepatitis B progression
Exhibit 05: Disease progression of hepatitis B
Exhibit 06: Significance of serological markers
Exhibit 07: Types of hepatitis B diagnostic tests
Exhibit 08: Diagnostic strategies for HBV
Exhibit 09: Interpretation of serological markers
Exhibit 10: Endemicity pattern of hepatitis B across different regions
Exhibit 11: Medical cost for chronic viral hepatitis
Exhibit 12: Progression of hepatitis C
Exhibit 13: Risk factors for hepatitis transmission
Exhibit 14: Screening tests for hepatitis C infection
Exhibit 15: Medical cost for hepatitis C and related infections
Exhibit 16: Reimbursement perspectives of healthcare entities
Exhibit 17: Global hepatitis B and C diagnostics market analysis: Developed and emerging markets
Exhibit 18: Snapshot of global hepatitis B and C diagnostics market
Exhibit 19: Global hepatitis B and C diagnostics market 2025-2020 ($ billions)
Exhibit 20: Opportunity analysis of hepatitis B and C diagnostics market
Exhibit 21: Five forces analysis
Exhibit 22: Global hepatitis B and C diagnostics market by procedure 2015-2020
Exhibit 23: Global hepatitis B and C diagnostics market by procedure 2015 ($ billions)
Exhibit 24: Global hepatitis B and C diagnostics market by procedure: Lifecycle analysis 2015
Exhibit 25: Global hepatitis B and C immunodiagnostics market 2025-2020 ($ billions)
Exhibit 26: Opportunity analysis of immunodiagnostics
Exhibit 27: Global hepatitis B and C immunodiagnostics market segmentation by product type 2015
Exhibit 28: Global hepatitis B and C NAT market 2025-2020 ($ millions)
Exhibit 29: Global hepatitis B and C NAT market segmentation by product type 2015
Exhibit 30: Opportunity analysis of global hepatitis B and C NAT market
Exhibit 31: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 ($ millions)
Exhibit 32: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 (%)
Exhibit 33: Global hepatitis B and C diagnostics market segmentation: Impact analysis 2015-2020
Exhibit 34: Global hepatitis B and C diagnostics market by disease type 2015-2020
Exhibit 35: Global hepatitis B and C diagnostics market by disease type 2015
Exhibit 36: Global hepatitis B and C diagnostics market by disease type: Lifecycle analysis 2015
Exhibit 37: Acute hepatitis B infection by demography 2015
Exhibit 38: Chronic hepatitis B infection by demography 2015
Exhibit 39: Procurement of hepatitis B diagnostic kits by WHO 2015
Exhibit 40: Global hepatitis B diagnostics market 2015-2020 ($ millions)
Exhibit 41: Opportunity analysis of global hepatitis B diagnostics market
Exhibit 42: Prevalence rates of hepatitis C across different regions 2015
Exhibit 43: Treatment cost of hepatitis C-related infections
Exhibit 44: Procurement of hepatitis C diagnostic kits by WHO 2015
Exhibit 45: Opportunity analysis of hepatitis C
Exhibit 46: Global hepatitis C diagnostics market 2015-2020 ($ billions)
Exhibit 47: Global hepatitis B and C diagnostics market by disease type 2015-2020 ($ millions)
Exhibit 48: Global hepatitis B and C diagnostics market by disease type 2015-2020 (%)
Exhibit 49: Global hepatitis B and C diagnostics segmentation by disease type
Exhibit 51: Geographical hepatitis B and C diagnostics market 2015
Exhibit 52: Global hepatitis B and C diagnostics: Regional market lifecycle analysis
Exhibit 53: Global hepatitis B and C diagnostics market by geography 2015-2020
Exhibit 54: Global hepatitis and C diagnostics market segmentation by geography 2015
Exhibit 55: Global hepatitis B and C diagnostics market by geography lifecycle analysis 2015
Exhibit 56: Hepatitis B and C diagnostics in Americas 2015
Exhibit 57: Prevalence data of hepatitis C in North America
Exhibit 58: Prevalence data of hepatitis C in Latin America
Exhibit 59: Hepatitis B and C diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 60: Prevalence data of hepatitis C in Europe
Exhibit 61: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 62: Prevalence rate of hepatitis B in APAC
Exhibit 63: Prevalence data of hepatitis C in APAC
Exhibit 64: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 65: Global hepatitis B and C diagnostics market by geography 2025-2020 ($ millions)
Exhibit 66: Global hepatitis B and C diagnostics market by geography 2025-2020 (%)
Exhibit 67: Global hepatitis B and C diagnostics market by geography
Exhibit 68: Strategies of healthcare organizations
Exhibit 69: Advantages of POC diagnostics
Exhibit 70: Recent and expected product launches of HCV POC diagnostic tests
Exhibit 71: Impact of drivers
Exhibit 72: Prevalence and diagnosis of HCV infections across developing countries 2015 (millions)
Exhibit 73: Key factors affecting the adoption rates
Exhibit 74: Force field analysis of global hepatitis b and C diagnostics market
Exhibit 75: Impact of drivers and challenges
Exhibit 76: Key advantages driving the adoption of HCV core antigen test
Exhibit 77: Impact of trends on global hepatitis B and C diagnostics market 2015-2020
Exhibit 78: Key leading vendors ranking for instruments 2015
Exhibit 79: Presence of vendors in the global hepatitis B and C diagnostics market
Exhibit 80: Abbott Laboratories: Key business offerings
Exhibit 81: Abbott Diagnostics: Metric analysis
Exhibit 82: Hoffmann-La Roche: Business segmentation by revenue 2015
Exhibit 83: Roche Diagnostics: Products and description
Exhibit 84: Roche Diagnostics: Business segmentation by revenue 2015
Exhibit 85: Roche Diagnostics: Metric analysis
Exhibit 86: Siemens Healthcare: Various tests available in multiple diseases
Exhibit 87: Siemens Healthcare: Metric analysis
Exhibit 88: QIAGEN: Metric analysis
...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top